Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jian Gu Injection is a Traditional Chinese Medicine (TCM) therapeutic developed and manufactured by Guangxi Nanning Baihui Pharmaceutical. It is a biologic product derived from fresh porcine bone, containing a complex mixture of polypeptides, amino acids, and essential minerals. The injection is primarily indicated for the treatment of degenerative bone and joint diseases, including osteoarthritis, bone hyperplasia (osteophytes), and various types of fractures. Its mechanism of action involves the stimulation of osteoblast proliferation and activity, which promotes bone formation and mineralization, while simultaneously improving local microcirculation and providing analgesic effects in the affected tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jian Gu Injection.